← Back to Clinical Trials
Recruiting NCT07208630

NCT07208630 Effect of Instrument-assisted Soft Tissue Mobilization on Functional and Cognitive Abilities in Elderly

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07208630
Status Recruiting
Phase
Sponsor Cairo University
Condition Functional Abilities
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-10-03
Primary Completion 2026-03

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Instrument-assisted soft tissue mobilizationTraditional physical therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-10-03 with a primary completion date of 2026-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

PURPOSE: To determine the effect of Instrument-assisted soft tissue mobilization on functional and cognitive abilities in elderly. BACKGROUND: There is an increased interest in health care with growth of the older population. Instrument-Assisted Soft Tissue Mobilization (IASTM) is a manual therapy technique using specially designed tools to apply pressure and mobilize soft tissues. It has gained attention as a non-invasive intervention that can aid in improving musculoskeletal health and overall function, especially in older adults. Given the aging population and the rise in age-related functional and cognitive decline, there is a pressing need for effective strategies to enhance quality of life in this demographic. In the elderly, musculoskeletal issues, such as reduced muscle flexibility, joint stiffness, and soft tissue restrictions, are common and can severely impact physical function. IASTM has been shown to increase tissue perfusion, reduce fascial restrictions, and improve joint mobility. These effects are critical in countering age-related declines in mobility, balance, and overall physical functionality, ultimately promoting greater independence and reducing fall risk. Improved physical function through IASTM may also influence cognitive health positively, as increased physical activity and mobility are linked to better cognitive outcomes in the elderly. HYPOTHESES: There will be no significant effect of Instrument-assisted soft tissue mobilization on functional and cognitive abilities in elderly. RESEARCH QUESTION: Does instrument-assisted soft tissue mobilization is effective on functional and cognitive abilities in elderly?

Eligibility Criteria

Inclusion Criteria: * 60 elderly subjects aged range from 65-75 years old will participant in the study from both genders. * had cognitive abilities to understand explanations and instructions * did not take any medication that can affect their balance. Exclusion Criteria: * They neither had sever musculoskeletal disorders * Nor neurological damage related to balance (dizziness, vestibular dysfunction) * Nor orthostatic hypotension * Nor health risk factors.

Contact & Investigator

Central Contact

Nouran Ahmed Ibrahim, lecturer

✉ nouran-312@cu.edu.eg

📞 +201062207203

Frequently Asked Questions

Who can join the NCT07208630 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 75 Years, studying Functional Abilities. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07208630 currently recruiting?

Yes, NCT07208630 is actively recruiting participants. Contact the research team at nouran-312@cu.edu.eg for enrollment information.

Where is the NCT07208630 trial being conducted?

This trial is being conducted at Giza, Egypt.

Who is sponsoring the NCT07208630 clinical trial?

NCT07208630 is sponsored by Cairo University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology